Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects

By sjmartinez • July 5, 2022

Maher TM, Bourdin A, Volkmann ER, Vettori S, Distler JHW, Alves M, Stock C, Distler O. Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects. Respir Res. 2022 Jul 5;23(1):178. doi: 10.1186/s12931-022-02095-6. PMID: 35790961; PMCID: PMC9258095.

Tags: Connective tissue diseases, Publications, Pulmonary fibrosis, Rheumatology, systemic Scleroderma, Vital capacity

Outcomes of isolated tricuspid replacement versus repair among older patients with tricuspid regurgitation in the United States

Shimoda TM, Ueyama HA, Miyamoto Y, Watanabe A, Gotanda H, Elmariah S, Yokoyama Y, Fukuhara S, Kaneko T, Kuno T, Tsugawa Y. Outcomes of isolated[...]

Corrigendum: Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response

Santos P, Rezende CP, Piraine R, Oliveira B, Ferreira FB, Carvalho VS, Calado RT, Pellegrini M, Almeida F. Corrigendum: Extracellular vesicles from human breast cancer-resistant[...]

Tailoring Chronic Disease Interventions to Meet Specific Needs of Women: A Case Example of a Hypertension Program

Dancu CA, Schexnayder J, Bosworth HB, Lewinski A, Shapiro A, Lanford T, Clark CW, Bean-Mayberry B, Zullig LL, Gierisch JM, Goldstein KM. Tailoring Chronic Disease[...]